Weidong Wang
Foshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study.
Journal: BMC medicine
Published: January 07, 2026
A radiomic model for noninvasive prediction of PD-L1 and VETC expression in hepatocellular carcinoma using enhanced abdominal CT.
Journal: Frontiers in oncology
Published: August 31, 2025
Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study.
Journal: Scientific reports
Published: March 16, 2025
m6A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 28, 2025
A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carcinoma patients: a tumor marker prognostic study.
Journal: International journal of surgery (London, England)
Published: December 18, 2024
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma.
Journal: Discover oncology
Published: November 14, 2024
Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study.
Journal: International journal of surgery (London, England)
Published: November 25, 2023
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: March 09, 2023
Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis.
Journal: Frontiers in oncology
Published: August 29, 2022
TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway.
Journal: European journal of medical research
Published: August 15, 2022
Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.
Journal: Frontiers in molecular biosciences
Published: November 05, 2021
Last Updated: 09/26/2026